NanoVibronix director Aurora Cassirer resigns effective April 1, 2025

ENvue Medical, Inc.

Cassirer resigned from the board and all committees (audit, governance, compensation) immediately.
Resignation not due to any disagreement with the company on operations, policies, or practices.
No replacement announced; board size reduced by one.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Aurora Cassirer

Director

FEED · ENvue Medical, Inc.

Effective: 2025-04-01
Filed: April 3, 2025, 7:59 PM ET

On April 1, 2025, Aurora Cassirer submitted her resignation as a member of the board of directors of NanoVibronix, Inc. (the “Company”), which resignation became effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Aurora Cassirer resigned as Director at ENvue Medical, Inc..

Action: resigned
Role: Director

Exact text from the filing

On April 1, 2025, Aurora Cassirer submitted her resignation as a member of the board of directors of NanoVibronix, Inc. (the “Company”), which resignation became effective immediately.

View on SEC.gov

ENvue Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-002556

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.